Innovation and Expertise
in Life Sciences Investing

Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in the industry since 1996. Our diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for our companies and our investors.

Portfolio News

January 05, 2009
Trevena - BusinessWeek's Most Sucessful Startups in 2008
December 09, 2008
AcelRx Feeling No Pain After Successful Phase II
December 04, 2008
Kiadis Pharma Announces Positive Clinical Results for ATIR™ in Mismatched Bone Marrow Transplantations
November 20, 2008
Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh-immunization Prevention Project
November 12, 2008
Biovitrum Extends ReFacto® Supply Agreement with Wyeth until December 31, 2015
November 06, 2008
Aegerion Pharmaceuticals, Inc. Announces AEGR-733 Phase II Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Hepatic Safety Profile

Alta Partners News

July 23, 2008
Market Conditions Sour IPO Prospects For Some Firms – MDMA Panelists
July 17, 2008
Who'll Stop the Pain?
January 10, 2008
JPMorgan Healthcare Conference

Esperion Therapeutics (spin-out)
Excaliard Pharmaceuticals
Immune Design Co.
MAKO Surgical
Sierra Surgical Technologies
Sonexa Therapeutics, Inc.
Sutro Biopharma
Taligen Therapeutics, Inc.
Trevena, Inc.
See our complete portfolio ...